120 related articles for article (PubMed ID: 25657901)
1. To evaluate efficacy and safety of Caralluma fimbriata in overweight and obese patients: A randomized, single blinded, placebo control trial.
Arora E; Khajuria V; Tandon VR; Sharma A; Mahajan A; Gillani ZH; Choudhary N
Perspect Clin Res; 2015; 6(1):39-44. PubMed ID: 25657901
[TBL] [Abstract][Full Text] [Related]
2. The effect of an orally-dosed Caralluma Fimbriata extract on appetite control and body composition in overweight adults.
Rao A; Briskey D; Dos Reis C; Mallard AR
Sci Rep; 2021 Mar; 11(1):6791. PubMed ID: 33762661
[TBL] [Abstract][Full Text] [Related]
3. A pilot study investigating the effect of Caralluma fimbriata extract on the risk factors of metabolic syndrome in overweight and obese subjects: a randomised controlled clinical trial.
Astell KJ; Mathai ML; McAinch AJ; Stathis CG; Su XQ
Complement Ther Med; 2013 Jun; 21(3):180-9. PubMed ID: 23642949
[TBL] [Abstract][Full Text] [Related]
4. Effect of Caralluma fimbriata extract on appetite, food intake and anthropometry in adult Indian men and women.
Kuriyan R; Raj T; Srinivas SK; Vaz M; Rajendran R; Kurpad AV
Appetite; 2007 May; 48(3):338-44. PubMed ID: 17097761
[TBL] [Abstract][Full Text] [Related]
5. Caralluma Fimbriata Supplementation Improves the Appetite Behavior of Children and Adolescents with Prader-Willi Syndrome.
Griggs JL; Su XQ; Mathai ML
N Am J Med Sci; 2015 Nov; 7(11):509-16. PubMed ID: 26713299
[TBL] [Abstract][Full Text] [Related]
6. The use of Caralluma fimbriata as an appetite suppressant and weight loss supplement: a systematic review and meta-analysis of clinical trials.
Jayawardena R; Francis TV; Abhayaratna S; Ranasinghe P
BMC Complement Med Ther; 2021 Nov; 21(1):279. PubMed ID: 34758791
[TBL] [Abstract][Full Text] [Related]
7. The effects of grape seed extract (Vitis vinifera) supplement on inflammatory markers, neuropeptide Y, anthropometric measures, and appetite in obese or overweight individuals: A randomized clinical trial.
Parandoosh M; Yousefi R; Khorsandi H; Nikpayam O; Saidpour A; Babaei H
Phytother Res; 2020 Feb; 34(2):379-387. PubMed ID: 31713941
[TBL] [Abstract][Full Text] [Related]
8. A randomised placebo controlled clinical trial on the efficacy of Caralluma fimbriata supplement for reducing anxiety and stress in healthy adults over eight weeks.
Kell G; Rao A; Katsikitis M
J Affect Disord; 2019 Mar; 246():619-626. PubMed ID: 30609411
[TBL] [Abstract][Full Text] [Related]
9. Modulatory effects of Caralluma fimbriata extract against high-fat diet induced abnormalities in carbohydrate metabolism in Wistar rats.
Gujjala S; Putakala M; Nukala S; Bangeppagari M; Rajendran R; Desireddy S
Biomed Pharmacother; 2017 Aug; 92():1062-1072. PubMed ID: 28618651
[TBL] [Abstract][Full Text] [Related]
10. Antiobesogenic and Antiatherosclerotic Properties of Caralluma fimbriata Extract.
Kamalakkannan S; Rajendran R; Venkatesh RV; Clayton P; Akbarsha MA
J Nutr Metab; 2010; 2010():285301. PubMed ID: 21234320
[TBL] [Abstract][Full Text] [Related]
11. Effect of rimonabant, a cannabinoid-1 receptor blocker, on weight and cardiometabolic risk factors in overweight or obese patients: RIO-North America: a randomized controlled trial.
Pi-Sunyer FX; Aronne LJ; Heshmati HM; Devin J; Rosenstock J;
JAMA; 2006 Feb; 295(7):761-75. PubMed ID: 16478899
[TBL] [Abstract][Full Text] [Related]
12. Phytochemical analysis and effects on ingestive behaviour of a Caralluma fimbriata extract.
Vitalone A; Di Sotto A; Mammola CL; Heyn R; Miglietta S; Mariani P; Sciubba F; Passarelli F; Nativio P; Mazzanti G
Food Chem Toxicol; 2017 Oct; 108(Pt A):63-73. PubMed ID: 28713048
[TBL] [Abstract][Full Text] [Related]
13. Spirulina platensis effectively ameliorates anthropometric measurements and obesity-related metabolic disorders in obese or overweight healthy individuals: A randomized controlled trial.
Yousefi R; Mottaghi A; Saidpour A
Complement Ther Med; 2018 Oct; 40():106-112. PubMed ID: 30219433
[TBL] [Abstract][Full Text] [Related]
14. Twelve weeks CLA supplementation decreases the hip circumference in overweight and obese women. A double-blind, randomized, placebo-controlled trial.
Mądry E; Chudzicka-Strugała I; Grabańska-Martyńska K; Malikowska K; Grebowiec P; Lisowska A; Bogdański P; Walkowiak J
Acta Sci Pol Technol Aliment; 2016; 15(1):107-113. PubMed ID: 28071044
[TBL] [Abstract][Full Text] [Related]
15. Use of sibutramine in obese mexican adolescents: a 6-month, randomized, double-blind, placebo-controlled, parallel-group trial.
García-Morales LM; Berber A; Macias-Lara CC; Lucio-Ortiz C; Del-Rio-Navarro BE; Dorantes-Alvárez LM
Clin Ther; 2006 May; 28(5):770-82. PubMed ID: 16861099
[TBL] [Abstract][Full Text] [Related]
16. Effect of the herbal medicines in obesity and metabolic syndrome: A systematic review and meta-analysis of clinical trials.
Payab M; Hasani-Ranjbar S; Shahbal N; Qorbani M; Aletaha A; Haghi-Aminjan H; Soltani A; Khatami F; Nikfar S; Hassani S; Abdollahi M; Larijani B
Phytother Res; 2020 Mar; 34(3):526-545. PubMed ID: 31793087
[TBL] [Abstract][Full Text] [Related]
17. Safety assessment of a hydroethanolic extract of Caralluma fimbriata.
Odendaal AY; Deshmukh NS; Marx TK; Schauss AG; Endres JR; Clewell AE
Int J Toxicol; 2013; 32(5):385-94. PubMed ID: 23771637
[TBL] [Abstract][Full Text] [Related]
18. Effects of oral α-lipoic acid administration on body weight in overweight or obese subjects: a crossover randomized, double-blind, placebo-controlled trial.
Li N; Yan W; Hu X; Huang Y; Wang F; Zhang W; Wang Q; Wang X; Sun K
Clin Endocrinol (Oxf); 2017 May; 86(5):680-687. PubMed ID: 28239907
[TBL] [Abstract][Full Text] [Related]
19. Efficacy of a novel herbal formulation for weight loss demonstrated in a 16-week randomized, double-blind, placebo-controlled clinical trial with healthy overweight adults.
Dixit K; Kamath DV; Alluri KV; Davis BA
Diabetes Obes Metab; 2018 Nov; 20(11):2633-2641. PubMed ID: 29923305
[TBL] [Abstract][Full Text] [Related]
20. Sibutramine is effective for weight loss and diabetic control in obesity with type 2 diabetes: a randomised, double-blind, placebo-controlled study.
Finer N; Bloom SR; Frost GS; Banks LM; Griffiths J
Diabetes Obes Metab; 2000 Apr; 2(2):105-12. PubMed ID: 11220522
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
